Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Marimed (MRMD) Net Margin (2016 - 2025)

Marimed (MRMD) has disclosed Net Margin for 15 consecutive years, with 11.14% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 1007.0% to 11.14% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 8.92% through Dec 2025, down 120.0% year-over-year, with the annual reading at 9.04% for FY2025, 116.0% down from the prior year.
  • Net Margin for Q4 2025 was 11.14% at Marimed, down from 7.21% in the prior quarter.
  • The five-year high for Net Margin was 23.3% in Q2 2021, with the low at 26.04% in Q4 2023.
  • Average Net Margin over 5 years is 2.07%, with a median of 2.88% recorded in 2023.
  • Peak annual rise in Net Margin hit 4880bps in 2021, while the deepest fall reached -5146bps in 2021.
  • Over 5 years, Net Margin stood at 20.61% in 2021, then skyrocketed by 164bps to 13.25% in 2022, then plummeted by -296bps to 26.04% in 2023, then increased by 19bps to 21.22% in 2024, then soared by 47bps to 11.14% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 11.14%, 7.21%, and 3.21% for Q4 2025, Q3 2025, and Q2 2025 respectively.